Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer

OBJECTIVES: Various genomic alterations and genomic signatures, including ERBB2 amplification, mutations in PIK3CA, AKT1, and ESR1, and tumor mutational burden (TMB), have become important biomarkers for treatment selection in breast cancer (BC). This study aimed to investigate the mutational featur...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096980/
https://www.ncbi.nlm.nih.gov/pubmed/33968723
http://dx.doi.org/10.3389/fonc.2021.618767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096980/
https://www.ncbi.nlm.nih.gov/pubmed/33968723
http://dx.doi.org/10.3389/fonc.2021.618767

Ejemplares similares